Heerlen, NL, 04 Nov 2015 07:15 CET
Royal DSM, a global science-based company active in health, nutrition and materials, today presents its updated corporate strategy, “Driving Profitable Growth” at its annual Capital Markets Day in Amsterdam (Netherlands).
Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: “We have transformed the company successfully into a science-based company in health, nutrition and materials. The global megatrends that drive our business remain highly relevant. Our focus on the growth drivers High Growth Economies, Innovation and Sustainability has created DSM’s current platform for growth.
Organic growth, supported by cost reductions and strict capital allocation will enable us to improve our financial results. This is reflected in the two targets set for the strategic period: EBITDA and ROCE growth.
We will extract significant value from the Pharma and Bulk Chemicals joint ventures in the coming years, providing financial headroom. We do not expect to engage in large acquisitions in the near future as we continue to integrate recent acquisitions, which have made a strong contribution to earnings.
Having made important steps in the strategic period behind us, DSM is now a more global, innovative and sustainable company with a portfolio and strategy geared at improving financial results.”
A conference call for the media was held at 09.00 (CET). A recording of this call can be found below. The DSM Capital Markets Day video webcast and presentations can be found below.